Abstract Delta9-tetrahydrocannabinol (Δ 9 -THC) is the major psychoactive component of the cannabis plant. Δ 9
SIV
+ and PBO/SIV − (n = 4/group). One-month after daily Δ 9 -THC or PBO administrations, macaques in groups one and three were challenged intravenously with pathogenic SIV mac251/CNS , which was isolated from the brain of a Chinese macaque with end-staged neuroAIDS. No significant differences in peak and steady state plasma viral loads were seen between Δ 9 -THC + SIV + and PBO/SIV + macaques. Regardless of Δ
9
-THC, all infected macaques displayed significant drop of CD4/CD8 T cell ratio, loss of CD4 + T cells and higher persistent levels of Ki67 + CD8 + T cells compared with uninfected animals. Moreover, long-term Δ 9 -THC treatment reduced significantly the frequency of circulating IgE + B cells. Only one Δ 9 -THC + SIV + macaque died of simian AIDS with paralyzed limbs compared with two deaths in the PBO/SIV + group during the study period. These findings indicate that chronic Δ Introduction Delta9-tetrahydrocannabinol (Δ 9 -THC) is the major psychoactive cannabinoid in the Cannabis sativa (Croxford 2003) . The biological function of Δ 9 -THC is mediated by interaction with two major G-protein-coupled cannabinoid receptors, namely CB1 and CB2 receptors (Felder and Glass 1998; Kaplan 2013; Pertwee 1997) . While the CB1 receptor is preferentially expressed in the brain as the mediator of cannabisinduced neurobehavioral effects, the CB2 receptor is found primarily in peripheral immune system such as on the surface of T and B cells (Ameri 1999; Gorantla et al. 2010; Kaplan 2013) . Theologically, the chronic administration of Δ 9 -THC may affect both central nerve system and immune system and, therefore, potentially modulate disease progression especially among patients infected with neurotropic HIV-1. This is a critical issue because the man-made Marinol, whose active ingredient is Δ 9 -THC, has been approved by the Food and Drug Administration as an appetite stimulant for the treatment of HIV-1-associated anorexia and weight loss (Abrams 1998; Riggs et al. 2012) . HIV-1-positive marijuana smokers produced substantial and comparable increases in food intake (Haney 2002; Haney et al. 2007) . However, the impact of Δ 9 -THC on HIV-1 infection remains under investigation. In vitro studies indicated that Δ 9 -THC decreased the constitutive production of IL-8, MIP-1alpha, MIP-1beta, and RANTES, changes that might worsen HIV-1 infection (Srivastava et al. 1998) . Moreover, Δ 9 -THC administration suppressed immune function and enhanced HIV-1 infection in huPBL-SCID mice with a significantly higher number of infected cells and increased viral loads (Roth et al. 2005) . Similar enhancement effects, however, were not found in a randomized, prospective, controlled trial comparing the use of marijuana cigarettes (3.95 % THC), dronabinol (2.5 mg), and oral placebo in HIV-1-infected adults taking protease inhibitor-containing highly active antiretroviral therapy (HAART) (Bredt et al. 2002) . One study indicated that Δ 9 -THC might reduce HIV-1 receptor expression on monocytes that diminished entry efficiency (Williams et al. 2014) . In non-human primate models, chronic treatment with Δ 9 -THC seemingly decreased plasma and CSF viral loads and tissue inflammation, reducing morbidity and mortality of SIV-infected male Indian macaques (Molina et al. 2011b) . Although there were no significant alterations in immune phenotype in animals, subsequent analysis indicated that Δ 9 -THC modulated duodenal T cell populations, favored a pro-Th2 cytokine balance, and decreased intestinal apoptosis (Molina et al. 2014) . In contrast, chronic Δ 9 -THC administration did not seem to protect SIV-infected female Indian rhesus macaques from early mortality (Amedee et al. 2014) . These findings call for continued efforts to understand the impact of chronic Δ 9 -THC in a separate SIV/macaque model. Based on these publications, we hypothesized that chronic Δ 9 -THC might affect morbidity and mortality in male SIVinfected Chinese-derived macaques. To test this hypothesis, we sought to determine the effects of long-term Δ 9 -THC treatment using four groups of a total of 16 male Chinese macaques with or without SIV mac251 infection.
Materials and Methods

Animals
Sixteen male Chinese rhesus macaques were housed in the facility at the Institute of Laboratory Animal Science (ILAS), Chinese Academy of Medical Sciences and Peking Union Medical College. They were negative in tests of SIV, herpes B virus, and simian T-lymphotropic virus. The Institutional Animal Care and Use Committee (IACUC) of Louisiana State University Health Sciences Center and ILAS approved our animal experimental protocols for ethics and care. Post infection, biospecimen collection was performed with animals under anesthesia using ketamine hydrochloride (10 mg/kg) in ILAS' Animal Bio-Safety Level 3 (ABSL-3) laboratory, which is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). -THC solution was stored in aliquots at −20°C, and prepared as an injectable emulsion. Consistently, chronic intramuscular injection of Δ 9 -THC occurred twice daily at 8:00 a.m. and 6:00 p.m. with a dose of 0.32 mg/kg for a total of 428 days. The dose and frequency of Δ 9 -THC (0.32 mg/kg, i.m., twice daily) were based on data previously generated in male rhesus macaques of Indian-origin (Molina et al. 2011b ). PBO control animals received time-matched intramuscular injections of equal volumes (0.05 ml/kg) of diluent.
Virus
The challenge stock was prepared in rhesus peripheral blood mononuclear cells (PBMCs) using SIV mac251/CNS, which was isolated from the brain of an end-staged Chinese macaque with simian AIDS and neurological disorders. The original SIV mac251 was kindly provided by Preston A. Marx. 
Viral Load Measurement by Quantitative Real-Time RT-PCR
RNA was isolated from 200 μl of cell-free plasma using the QIAmp viral RNA minikit (Qiagen, Valencia, CA). The RNA was eluted in 20 μl of nuclease free water and frozen immediately at −80°C until analysis. Plasma viral RNA loads were m e a s u r e d b y a q u a n t i t a t i v e r e a l -t i m e r e v e r s e transcription-PCR (qRT-PCR) assay for SIV gag with the 5′-primer GCAGA GGAGG AAATT ACCCA GTAC, 3′-primer CAATT TTACC CAGGC ATTTA ATGTT, and the probe FAM-ACCTG CCATT AAGCC CGA-MGB in the PerkinElmer ABI 7500 machine. Pre-standardized SIV mac251 gag cDNA was used as a positive control. Triplicate test reactions were performed for each sample.
Phenotyping of Peripheral T and B Cells
Peripheral blood samples were collected into ethylene diamine tetra-acetic acid (EDTA) anticoagulant tubes for the extraction and isolation of plasma by density gradient centrifugation. Flow cytometry was performed for the staining of T lymphocytes as we previously described (Chen et al. 2000; Chen et al. 2002; Wang et al. 2010) . Peripheral CD4 + T-cell counts were calculated by multiplying the percentage of CD3 + CD4
+ T cells with the total CD3 + T lymphocytes using the BD Trucount™ method. One million peripheral blood mononuclear cells were stained with the following sets of monoclonal antibodies: CD8-PerCP (clone SK1), CD4-APC-Cy7 (clone SK3), CD3-PE (clone SP34), Ki-67-FITC (clone B56); IgE-APC (clone MB10-5C4), CD20-APC-Cy-7 (clone L27) (Xue et al. 2013) . All the antibodies were purchased from BD Biosciences (San Jose, CA, USA). After washing with cold flow wash buffer, the cells were fixed with 1 % paraformaldehyde and subjected to flow cytometry analysis within 24 h. Samples were acquired and analyzed on a BD LSRII flow cytometer with the FACS DIVA Software (BD Biosciences). FACS data were evaluated using the FLOWJO Version 8.7 Software (Tree Star, Ashland, OR, USA).
Statistical Analysis
Statistical analysis and graphical presentations were generated by GRAPHPAD PRISM software (GraphPad Software, La Jolla, CA, USA). One-way ANOVA analysis was performed for differences between multiple groups. Paired student t test was used to compare intragroup data. Two-tailed and unpaired student t tests were used for comparison between two groups. The Kaplan-Meier survival graph between two groups was analyzed with Log-rank test. The potential correlation between variables was analyzed with Pearson's correlation test. P ≤ 0.05 was considered statistically significant.
Results
Chronic Δ 9 -THC Administration Does not Enhance Viral Load and Disease Progression Post SIV Infection According to our experimental design (Fig. 1a) , 16 male rhesus macaques of Chinese-origin were divided into four study groups:
PBO/SIV + (G3) and PBO/SIV − (G4) with four macaques in each group. We aimed to determine the effects of chronic Δ 9 -THC on male Chinese macaques in the presence and absence of SIV infection. G1 and G2 animals received Δ 9 -THC daily for a total of 428 days. Thirty days after the pre-Δ 9 -THC treatment G1 and G3 macaques were challenged intravenously with 100 TCID 50 pathogenic SIV mac251/CNS , whereas G2 and G4 served as uninfected PBO controls. The infection was successful because all animals in G1 and G3 displayed comparable peak viral load and steady-state viremia (Fig. 1b and  1c) . The plasma viral loads reached their peak to approximately 10 7 -10 8 copies per ml around 14 days post viral inoculation in all eight infected macaques (Fig. 1b and 1c) . The average viral loads of both groups were around 10 5 copies per ml at steady state. Statistical analysis did not reveal any significance for both peak and steady-state viral loads between G1 and G3. Similar findings were also obtained when proviral loads were measured (data not shown). Chronic Δ 9 -THC, therefore, unlikely enhances viral loads during the course of SIV mac251/CNS infection. One macaque in G3 maintained high viral load and died of simian AIDS around 220 days post infection. Subsequently, another two infected animals, one in G3 and one in G1, died with relative high viral loads. Survival analysis, however, did not show statistical significance between G1 and G3 (Fig. 1c) . Chronic Δ 9 -THC did not significantly alter disease progression during the course of SIV mac251/CNS infection. + T cell count is another critical biomarker for measuring immunodeficiency and disease development during SIV infection. In order to further understand if chronic Δ 9 -THC affected CD4 T cells during the course of SIV infection, we measured CD4 count and CD4/CD8 ratio of each animal over time by standard protocols as we described previously (Chen et al. 2000; Chen et al. 2002) . While viral loads reached peak around 14 days post infection, there were significant reductions of CD4 count among infected monkeys in G1 and some in G3 (Fig. 2a, left) . Moreover, the mean CD4 loss was clearly evident among SIV-infected animals in G1 and G3 throughout the chronic phase of infection but not among uninfected monkeys in G2 and G4 (Fig. 2a, right ). There were, however, no significant differences in CD4 counts between G1 and G3 animals during both acute and chronic stages of infection. Chronic Δ 9 -THC alone did not seem to affect CD4 counts among uninfected macaques. In addition to CD4 count changes, SIV mac251/CNS acute infection resulted in rapid drops of CD4/CD8 ratios in G1 and G3, which were not found with control animals in G2 and G4 (Fig. 2b, left) . Subsequently, the mean CD4/CD8 ratios in G1 and G3 remained lower than those of uninfected animals in G2 and G4 (Fig. 2b, right) . Critically, similar to CD4 counts, there were no overall statistical differences in CD4/CD8 ratios between G1 and G3, suggesting that Δ 9 -THC administration did not alter CD4 loss following SIV infection.
SIV-induced Proliferation of CD8
+ T Cells Contributes to Abnormal CD4/CD8 Ratios During SIV infection highly increased T-cell turnover and immune activation may cause exhaustion of T cell production and function in rhesus monkeys (Sopper et al. 2003) . Because CB2 receptor is expressed Fig. 2 Measurement of CD4 counts and CD4/CD8 ratios of all experimental macaques. a CD4 counts or mean CD4 counts were measured at the acute phase of peak viremia on day 14 post infection (left) and overtime (right), respectively, by FACS analysis. b CD4/CD8 ratios or mean CD4/CD8 ratios were measured at the acute phase of peak viremia on day 14 post infection (left) and overtime (right), respectively, by FACS analysis. Paired student t test was used to analyze the statistical significance for changes of CD4 counts and CD4/CD8 ratios in each animal on the surface of T cells (Rom and Persidsky 2013) , we aimed to investigate if Δ 9 -THC could influence T cell proliferation by measuring the expression of the Ki-67 nuclear antigen in peripheral blood CD4 + and CD8 + T cell subpopulations. Similar to CD4 count changes described above, there were significant reductions of Ki-67 + CD4 T cell frequency among infected monkeys in both G1 and G3 while viral loads reached peak around 14 days post infection (Fig. 3a, left) . There were no significant differences in Ki-67 + CD4 T cell frequency between G1 and G3 animals during both acute and chronic stages of infection. After the acute phase, the mean Ki-67 + CD4 T cell frequency did not show distinct profiles compared with uninfected animals in G2 and G4. More striking findings were made when Ki-67 + CD8 T cell frequency was analyzed. SIV mac251/CNS infection resulted in a rapid increase in Ki-67 + CD8 T cell proliferation. There were rapid and significant increases of Ki-67 + CD8 T cell frequency among infected monkeys in both G1 and G3 compared with uninfected ones in G2 and G4 (Fig. 3b, left) . Subsequently, the mean Ki-67 + CD8 T cell frequency among SIV-infected animals in G1 and G3 was sustained at levels relatively higher than those of uninfected ones in G2 and G4 throughout the chronic phase of infection (Fig. 3b, right) . Correlation analysis indicated that the Ki-67 + CD8 T cell frequency was somewhat inversely associated with the drop of CD4/CD8 ratios (p = 0.041) but neither with viral load or nor with CD4 count. -THC administration did not seem to alter the course SIV infection during both acute and chronic phases, it raised a critical question on whether or not this active ingredient of Marinol was biologically active in experimental animals. To answer this question, we measured the body weights of each animal during the study period. The rationale was that Δ 9 -THC might improve food intake and, therefore, help to maintain a better body weight compared with PBO groups. We, however, did not see statistical significance between G1 and G3 (or G2 and G4). Interestingly, one previous study indicated that Δ 9 -THC treatment influenced the production of IgE + B cells in vivo. Since CB2 receptor on the surface of B cells was found in IgE down-regulation in mice (Newton and Klein 2012) , we sought to determine if Δ 9 -THC could affect IgE + B cells in experimental monkeys. We found that SIV mac251/CNS infection led to rapid decreases of B cell frequency in both G1 and G3 at 14 days post infection (Fig. 4a, left) , probably due to the rapid CD8 + T cell expansion among total lymphocytes. A similar trend was also found for IgE + B subsets but no statistical significance in this difference was achieved (Fig. 4b, left) . Interestingly, there were significant differences on IgE + B cells using the one-way ANOVA under the Newman-Keuls analysis (p ≤ 0.0001) when we compared these four groups during the time period of day 168-256. Regardless of SIV infection, when we compared Δ 9 -THC treated macaques in + T cells in each group were measured at the acute phase of peak viremia on day 14 post infection (left) and overtime (right), respectively, by FACS analysis. Paired student t test was used to analyze the indicated statistical significance G1 and G2 (n = 8) with those of untreated in G3 and G4 (n = 8), there was an increased trend of total B cells among total PBMCs tested during this chronic steady stage of infection (e.g. day 231) (Fig. 4a, right) . During the same time period, however, we found that the frequency of IgE + B cells was significantly reduced among eight macaques in G1 and G2 compared with ones in G3 and G4 (Fig. 4b, right) . After this time period, SIV disease progression in G3 probably led to the reduced frequency of IgE + B cells and, therefore, the statistical analysis was no longer significant.
Discussion
In this study, to the best of our knowledge we report the first study of cannabinoid effects on healthy and SIV-infected male rhesus monkeys of Chinese origin. Unlike Δ 9 -THC-mediated HIV-1 infection enhancement in huPBL-SCID mice (Roth et al. 2005) or Δ 9 -THC-associated plasma viral load reduction in SIV-infected male Indian macaques (Molina et al. 2011b) , we found that Δ 9 -THC neither enhanced nor attenuated SIV mac251/CNS infection in our model system. This conclusion was based on our longitudinal study of viral loads, CD4 counts, CD4/CD8 ratios, T cell proliferation, survival rate and clinical signs of disease progression in the context of continuous daily Δ 9 -THC administration for 428 days. We found that there were no significant differences in peak and steady state plasma viral loads as well as AIDS disease progression among SIV mac251/ CNS -infected animals with or without sustained Δ 9 -THC treatment. Moreover, regardless of Δ
9
-THC administration all infected macaques displayed significant drop of CD4/CD8 T cell ratios, loss of CD4 + T cells and higher levels of persistent Ki67 + CD8 + T cell proliferation compared with uninfected animals. The main biological effects of Δ 9 -THC seen in this study, down-regulation of circulating IgE + B cells in vivo, warrants future studies to explore mechanisms involved.
The initial finding of Δ 9 -THC-attenuated progression of SIV-infection was made in male rhesus macaques of Indian origin (Molina et al. 2011a; Molina et al. 2011b) . Using the same experimental protocols, we made similar observations in male rhesus macaques of Chinese origin in that Δ 9 -THC treatment of SIV-infected animals produced no significant effects on decreased CD4/CD8 ratio and increased CD8 + T cell proliferation. Moreover, two macaques in G3 died earlier than one in G1 after they developed clinical signs of disease (e.g. low CD4 count, weight loss and wasting). We, however, did not observe Δ 9 -THC-mediated attenuation of plasma viral loads or decreased early mortality of SIV infection with statistical significance. The differences observed between two monkey species might be due to multiple variable factors including the susceptibility of male Chinese macaques to Δ 9 -THC treatment and SIV infection, the optimal dose of Δ 9 -THC and different SIV strains inoculated. These are relevant factors because for example it has been previously documented that SIV mac251 infection 
